{"id":19193,"date":"2021-12-06T18:00:37","date_gmt":"2021-12-06T17:00:37","guid":{"rendered":"https:\/\/ppr-antibioresistance.inserm.fr\/?p=19193"},"modified":"2021-12-06T18:00:40","modified_gmt":"2021-12-06T17:00:40","slug":"pre-announcement-jpiamr-diagnostics-and-surveillance-networks","status":"publish","type":"post","link":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/calls-for-projects\/pre-announcement-jpiamr-diagnostics-and-surveillance-networks\/","title":{"rendered":"Pre-announcement: JPIAMR Diagnostics and Surveillance Networks"},"content":{"rendered":"\n<p>JPIAMR will launch in 2022 a transnational network call under the umbrella of the JPIAMR and within the framework of the ERA-NET JPIAMR-ACTION. The call\u00a0<em><a href=\"https:\/\/www.jpiamr.eu\/calls\/network-call-2022\/\" target=\"_blank\" rel=\"noreferrer noopener\">Diagnostics and Surveillance Networks<\/a><\/em>\u00a0involves funding organisations from 11 countries to date. Networks can be funded with a maximum of 50,000 Euro each.<\/p>\n\n\n\n<p>The aim of this call is to assemble networks of leading experts and stakeholders with an intent to facilitate the development, optimisation and use of diagnostic and surveillance tools, technologies and systems. Networks should work towards the conceptualisation of ideas in order to provide white papers, guidance documents and\/or best practices\/roadmaps and evidence frameworks to identify key questions to be addressed and\/or potential solutions to overcome barriers to enhanced surveillance and advanced diagnostics to reduce the burden of AMR.<\/p>\n\n\n\n<p>Eleven (11) JPIAMR-ACTION members are participating in this network call to date. Each network coordinator will be able to apply for a maximum of 50,000 Euro for 12 or 24 months period for support of its activities.<\/p>\n\n\n\n<p>The call opens in April 2022.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"information-application\">Information &amp; application<\/h2>\n\n\n\n<p>The full call text and the link to the online submission platform will be published when the call opens.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Timeline<\/h3>\n\n\n\n<p>22 March 2022 \u2013 Detailed pre-announcement text available<\/p>\n\n\n\n<p>12 April 2022 \u2013 Call opens<\/p>\n\n\n\n<p>28 April 2022 \u2013 Webinar for applicants<\/p>\n\n\n\n<p>14 June 2022 \u2013 Proposal deadline<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"funders\">Funders<\/h2>\n\n\n\n<p><strong>Egypt<\/strong><br>The Academy of Scientific Research and Technology (ASRT)<\/p>\n\n\n\n<p><strong>Estonia<\/strong><br>Estonian Research Council (ETAg)<\/p>\n\n\n\n<p><strong>France<\/strong><br>Agence Nationale de la Recherche (ANR)<\/p>\n\n\n\n<p><strong>Italy<\/strong><br>Ministero della Salute (It-MoH)<\/p>\n\n\n\n<p><strong>Lithuania<\/strong><br>Research Council of Lithuania (RCL)<\/p>\n\n\n\n<p><strong>Moldova<\/strong><br>Agentia Nationala Pentru Cercetare Si Dezvoltare (ANCD)<\/p>\n\n\n\n<p><strong>Netherlands<\/strong><br>Zorgonderzoek Nederland Zon (ZonMw)<\/p>\n\n\n\n<p><strong>Norway<\/strong><br>Research Council of Norway (RCN)<\/p>\n\n\n\n<p><strong>Spain<\/strong><br>Instituto de Salud Carlos III (ISCIII)<\/p>\n\n\n\n<p><strong>Sweden<\/strong><br>Swedish Research Council (SRC)<\/p>\n\n\n\n<p><strong>United Kingdom<\/strong><br>Medical Research Council (UKRI\/MRC)<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"supported-projects\">Supported projects<\/h2>\n\n\n\n<p>No supported projects found<\/p>\n\n\n\n<p>More <a href=\"https:\/\/www.jpiamr.eu\/calls\/network-call-2022\/\" target=\"_blank\" rel=\"noreferrer noopener\">on this page<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>JPIAMR will launch in 2022 a transnational network call under the umbrella of the JPIAMR and within the framework of the ERA-NET JPIAMR-ACTION. The call\u00a0Diagnostics and Surveillance Networks\u00a0involves funding organisations from 11 countries to date. Networks can be funded with a maximum of 50,000 Euro each. The aim of this call is to assemble networks [&hellip;]<\/p>\n","protected":false},"author":139,"featured_media":19201,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[59],"tags":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pre-announcement: JPIAMR Diagnostics and Surveillance Networks - French\u00a0National ANTIBIOTIC RESISTANCE Portal<\/title>\n<meta name=\"description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/calls-for-projects\/pre-announcement-jpiamr-diagnostics-and-surveillance-networks\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pre-announcement: JPIAMR Diagnostics and Surveillance Networks - French\u00a0National ANTIBIOTIC RESISTANCE Portal\" \/>\n<meta property=\"og:description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/calls-for-projects\/pre-announcement-jpiamr-diagnostics-and-surveillance-networks\/\" \/>\n<meta property=\"og:site_name\" content=\"French\u00a0National ANTIBIOTIC RESISTANCE Portal\" \/>\n<meta property=\"article:published_time\" content=\"2021-12-06T17:00:37+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-12-06T17:00:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/12\/JPIAMR-15thCall.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"741\" \/>\n\t<meta property=\"og:image:height\" content=\"378\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"\u00c9milie Noguez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"\u00c9milie Noguez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/calls-for-projects\/pre-announcement-jpiamr-diagnostics-and-surveillance-networks\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/calls-for-projects\/pre-announcement-jpiamr-diagnostics-and-surveillance-networks\/\"},\"author\":{\"name\":\"\u00c9milie Noguez\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3\"},\"headline\":\"Pre-announcement: JPIAMR Diagnostics and Surveillance Networks\",\"datePublished\":\"2021-12-06T17:00:37+00:00\",\"dateModified\":\"2021-12-06T17:00:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/calls-for-projects\/pre-announcement-jpiamr-diagnostics-and-surveillance-networks\/\"},\"wordCount\":290,\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/calls-for-projects\/pre-announcement-jpiamr-diagnostics-and-surveillance-networks\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/12\/JPIAMR-15thCall.jpg\",\"articleSection\":[\"Calls for projects\"],\"inLanguage\":\"en-GB\"},{\"@type\":[\"WebPage\",\"ItemPage\"],\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/calls-for-projects\/pre-announcement-jpiamr-diagnostics-and-surveillance-networks\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/calls-for-projects\/pre-announcement-jpiamr-diagnostics-and-surveillance-networks\/\",\"name\":\"Pre-announcement: JPIAMR Diagnostics and Surveillance Networks - French\u00a0National ANTIBIOTIC RESISTANCE Portal\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/calls-for-projects\/pre-announcement-jpiamr-diagnostics-and-surveillance-networks\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/calls-for-projects\/pre-announcement-jpiamr-diagnostics-and-surveillance-networks\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/12\/JPIAMR-15thCall.jpg\",\"datePublished\":\"2021-12-06T17:00:37+00:00\",\"dateModified\":\"2021-12-06T17:00:40+00:00\",\"description\":\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.\",\"breadcrumb\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/calls-for-projects\/pre-announcement-jpiamr-diagnostics-and-surveillance-networks\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/calls-for-projects\/pre-announcement-jpiamr-diagnostics-and-surveillance-networks\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/calls-for-projects\/pre-announcement-jpiamr-diagnostics-and-surveillance-networks\/#primaryimage\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/12\/JPIAMR-15thCall.jpg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/12\/JPIAMR-15thCall.jpg\",\"width\":741,\"height\":378,\"caption\":\"Cr\u00e9dit : JPIAMR\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/calls-for-projects\/pre-announcement-jpiamr-diagnostics-and-surveillance-networks\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Practical info &amp; communications\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Calls for projects\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/calls-for-projects\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Pre-announcement: JPIAMR Diagnostics and Surveillance Networks\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/\",\"name\":\"French\u00a0National ANTIBIOTIC RESISTANCE Portal\",\"description\":\"INSERM - From science to health\",\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization\",\"name\":\"Inserm\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"width\":1,\"height\":1,\"caption\":\"Inserm\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3\",\"name\":\"\u00c9milie Noguez\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pre-announcement: JPIAMR Diagnostics and Surveillance Networks - French\u00a0National ANTIBIOTIC RESISTANCE Portal","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/calls-for-projects\/pre-announcement-jpiamr-diagnostics-and-surveillance-networks\/","og_locale":"en_GB","og_type":"article","og_title":"Pre-announcement: JPIAMR Diagnostics and Surveillance Networks - French\u00a0National ANTIBIOTIC RESISTANCE Portal","og_description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","og_url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/calls-for-projects\/pre-announcement-jpiamr-diagnostics-and-surveillance-networks\/","og_site_name":"French\u00a0National ANTIBIOTIC RESISTANCE Portal","article_published_time":"2021-12-06T17:00:37+00:00","article_modified_time":"2021-12-06T17:00:40+00:00","og_image":[{"width":741,"height":378,"url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/12\/JPIAMR-15thCall.jpg","type":"image\/jpeg"}],"author":"\u00c9milie Noguez","twitter_card":"summary_large_image","twitter_misc":{"Written by":"\u00c9milie Noguez","Estimated reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/calls-for-projects\/pre-announcement-jpiamr-diagnostics-and-surveillance-networks\/#article","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/calls-for-projects\/pre-announcement-jpiamr-diagnostics-and-surveillance-networks\/"},"author":{"name":"\u00c9milie Noguez","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3"},"headline":"Pre-announcement: JPIAMR Diagnostics and Surveillance Networks","datePublished":"2021-12-06T17:00:37+00:00","dateModified":"2021-12-06T17:00:40+00:00","mainEntityOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/calls-for-projects\/pre-announcement-jpiamr-diagnostics-and-surveillance-networks\/"},"wordCount":290,"publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/calls-for-projects\/pre-announcement-jpiamr-diagnostics-and-surveillance-networks\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/12\/JPIAMR-15thCall.jpg","articleSection":["Calls for projects"],"inLanguage":"en-GB"},{"@type":["WebPage","ItemPage"],"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/calls-for-projects\/pre-announcement-jpiamr-diagnostics-and-surveillance-networks\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/calls-for-projects\/pre-announcement-jpiamr-diagnostics-and-surveillance-networks\/","name":"Pre-announcement: JPIAMR Diagnostics and Surveillance Networks - French\u00a0National ANTIBIOTIC RESISTANCE Portal","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/calls-for-projects\/pre-announcement-jpiamr-diagnostics-and-surveillance-networks\/#primaryimage"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/calls-for-projects\/pre-announcement-jpiamr-diagnostics-and-surveillance-networks\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/12\/JPIAMR-15thCall.jpg","datePublished":"2021-12-06T17:00:37+00:00","dateModified":"2021-12-06T17:00:40+00:00","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","breadcrumb":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/calls-for-projects\/pre-announcement-jpiamr-diagnostics-and-surveillance-networks\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/calls-for-projects\/pre-announcement-jpiamr-diagnostics-and-surveillance-networks\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/calls-for-projects\/pre-announcement-jpiamr-diagnostics-and-surveillance-networks\/#primaryimage","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/12\/JPIAMR-15thCall.jpg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/12\/JPIAMR-15thCall.jpg","width":741,"height":378,"caption":"Cr\u00e9dit : JPIAMR"},{"@type":"BreadcrumbList","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/calls-for-projects\/pre-announcement-jpiamr-diagnostics-and-surveillance-networks\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/"},{"@type":"ListItem","position":2,"name":"Practical info &amp; communications","item":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/"},{"@type":"ListItem","position":3,"name":"Calls for projects","item":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/calls-for-projects\/"},{"@type":"ListItem","position":4,"name":"Pre-announcement: JPIAMR Diagnostics and Surveillance Networks"}]},{"@type":"WebSite","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website","url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/","name":"French\u00a0National ANTIBIOTIC RESISTANCE Portal","description":"INSERM - From science to health","publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization","name":"Inserm","url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","width":1,"height":1,"caption":"Inserm"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3","name":"\u00c9milie Noguez"}]}},"publishpress_future_action":{"enabled":false,"date":"2026-04-11 23:24:09","action":"change-status","newStatus":"private","terms":[],"taxonomy":"category"},"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts\/19193"}],"collection":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/users\/139"}],"replies":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/comments?post=19193"}],"version-history":[{"count":8,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts\/19193\/revisions"}],"predecessor-version":[{"id":19213,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts\/19193\/revisions\/19213"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/media\/19201"}],"wp:attachment":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/media?parent=19193"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/categories?post=19193"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/tags?post=19193"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}